Spectral Medical Inc.

TSX:EDT.TO

Medical - Diagnostics & Research

Healthcare
$1.04 -1.45%

-$0.02 today

Market cap
$306.00M
Beta
0.23
P/E (TTM)
-10.5
EPS (TTM)
-$0.13
52W Low $0.77High $1.84

Volume 0.02M

Average 0.06M

EDT.TO Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Spectral Medical Inc.TSX: EDT.TO

Gross Profit · Q1 FY2026 · quarter ended Mar 2026

Gross profit turns negative

Q1 FY2026 gross profit was -CA$2.04M, compared with CA$447K a year earlier. Trailing-twelve-month gross profit was -CA$2.19M.

Context

  • Gross profit amounted to 211.1% of revenue in FY2025, up 166.6 pp from a year earlier.
  • Gross profit increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly gross profit holds near -CA$2.04M or moves back toward the trailing-twelve-month quarterly average of -CA$547K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$2.04M-77.0% QoQ
Last fiscal yearDec 2025
-CA$5.16M-606.5% YoY
LTMMar 2026
-CA$2.19M-303.3% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-556.6%——
1 year-606.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Gross Profit history

CAD · from the income statement

Latest · FY2025
(5.16M) CAD
Year-over-year change
-606.5%

Gross Profit vs competitors

How EDT.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -303.3% is the lowest of 8, against a peer median of +0.6%.
  • Gross profit amounts to 79.2% of revenue for EDT.TO, versus a peer median of 65.6%.
EDT.TO Competitors
Gross Profit for EDT.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$100.28M CAD-46.5%—31.5%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$73.53M CAD-7.5%—23.6%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$47.19M USD+69.1%+204.4%92.2%
KSI.TOKneat.com, Inc.LTM Mar 2026CA$39.98M CAD+0.6%+33.3%60.1%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$37.95M USD+33.5%+26.5%74.5%
PRN.TOProfound Medical Corp.LTM Mar 2026$13.33M USD+74.9%+56.6%71.0%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026-$281.1K USD-30.3%——
EDT.TOSpectral Medical Inc.LTM Mar 2026-CA$2.19M CAD-303.3%—79.2%
Peer median (excluding EDT.TO) —+0.6%+44.9%65.6%

Competitors are the stored peer set for EDT.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2M1.67M1.6M2.29M2.44M
Cost of Revenue832K684K936K1.27M7.6M
Gross Profit1.16M983K662K1.02M(5.16M)
Gross Margin58.3%59.0%41.4%44.5%-211.1%
Research & Development004.68M3.97M4.33M
Selling, General & Admin7.01M8.64M11.29M11.62M11.73M
Operating Expenses7.86M9.43M12.08M13.02M6.53M
Depreciation & Amortization294K272K218K251K250K
EBITDA(6.38M)(7.18M)(13.96M)(11.97M)(11.44M)
EBITDA Margin-319.4%-430.7%-873.3%-523.5%-468.3%
Operating Income(6.66M)(8.45M)(11.42M)(12M)(11.69M)
Operating Margin-333.5%-506.7%-714.7%-524.8%-478.5%
Interest Income00005.39M
Interest Expense28K176K1.33M3.18M5.16M
Other Income / Expenses(40K)819K(4.09M)(3.4M)(36M)
Income Before Tax(6.96M)(7.63M)(15.51M)(15.4M)(47.69M)
Pre-Tax Margin-348.6%-457.6%-970.4%-673.4%-1952.9%
Income Tax Expense00000
Net Income(8.79M)(11.28M)(15.66M)(15.4M)(47.69M)
Net Margin-440.1%-676.7%-980.1%-673.8%-1953.0%
EPS (Basic)(0.03)(0.04)(0.06)(0.05)(0.17)
EPS (Diluted)(0.03)(0.04)(0.06)(0.05)(0.17)
Weighted Avg Shares252.46M269.84M278.56M281.08M287.21M
Weighted Avg Shares (Diluted)252.46M269.84M278.56M281.08M287.21M

Spectral Medical Inc.

TSX:EDT.TO

Intrinsic Alpha fair value

Locked

Current Price

$1.04

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.